Emerging Treatment Options for Patients with NSCLC with ALK Rearrangements
Experts on non–small cell lung cancer discuss recent data on brigatinib and lorlatinib for the treatment of patients with ALK rearrangements.
Source: onclive.com
Stay updated with breaking news from Crown Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts on non–small cell lung cancer discuss recent data on brigatinib and lorlatinib for the treatment of patients with ALK rearrangements.
For the third consecutive year, Democratic Rep. Kamia Brown has introduced the Crown Act. The legislation, which has been signed into law in 14 states, prohibits race-based hair discrimination. Florida is not one of those states.
Third time’s a charm to prohibit race-based hair discrimination?